scispace - formally typeset
R

Robert D. Stone

Researcher at University of California, San Francisco

Publications -  14
Citations -  642

Robert D. Stone is an academic researcher from University of California, San Francisco. The author has contributed to research in topics: Uvea & End-diastolic volume. The author has an hindex of 11, co-authored 14 publications receiving 628 citations. Previous affiliations of Robert D. Stone include Université de Montréal.

Papers
More filters
Journal ArticleDOI

Monocular Axial Myopia Associated with Neonatal Eyelid Closure in Human Infants

TL;DR: Clinical findings and ultrasonographic biometric measurements suggested that axial elongation of the eye may occur as a result of neonatal eyelid closure, a finding similar to that for experimental myopia produced in neonatal animals after eyelid fusion.
Journal ArticleDOI

Epidemic Postsurgical Candida Parapsilosis Endophthalmitis: Clinical Findings and Management of 15 Consecutive Cases

TL;DR: In this paper, 15 cases of postoperative Candida parapsilosis endophthalmitis occurring secondary to a contaminated lot of an irrigating solution were studied, and all patients underwent a vitreous tap or diagnostic and therapeutic vitrectomy.
Journal ArticleDOI

Uveal melanoma radiation. 125I brachytherapy versus helium ion irradiation.

TL;DR: In this article, the authors analyzed the control and complication rates of uveal melanomas treated with helium ions or 125 I plaques and found that approximately 89% of eyes were retained and less than 4% of treated eyes were removed because of failure to control the tumor.
Journal ArticleDOI

Neovascular Glaucoma After Helium Ion Irradiation for Uveal Melanoma

TL;DR: Neovascular glaucoma developed in 22 of 169 uveal melanoma patients treated with helium ion irradiation and occurred more commonly in larger tumors; the incidence was not affected by tumor location, presence of subretinal fluid, nor rate of tumor regression.
Journal ArticleDOI

Effect of various doses of radiation for uveal melanoma on regression, visual acuity, complications, and survival.

TL;DR: Radiation dose level did not affect survival, complications, visual outcome, or tumor regression in this model, and the minimum radiation dose necessary to achieve tumor control with charged particles may be less than 50 GyE.